Reply to Eleuteri
et al.
: High-Dose Inhaled Nitric Oxide in Acute Hypoxemic Respiratory Failure: Need for Patient Phenotyping?
Am J Respir Crit Care Med
.
2024 Feb 15;209(4):460-462.
doi: 10.1164/rccm.202311-2112LE.
Authors
Naman S Shetty
1
,
Mokshad Gaonkar
1
,
Valentina Giammatteo
2
3
,
Pankaj Arora
1
4
,
Lorenzo Berra
2
5
6
3
Affiliations
1
Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.
2
Department of Anesthesia, Critical Care and Pain Medicine.
3
Harvard Medical School, Boston, Massachusetts; and.
4
Section of Cardiology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama.
5
Anesthesia Critical Care Center for Research, and.
6
Respiratory Care Services, Massachusetts General Hospital, Boston, Massachusetts.
PMID:
38128097
PMCID:
PMC10878377
DOI:
10.1164/rccm.202311-2112LE
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Comment
MeSH terms
Administration, Inhalation
Humans
Nitric Oxide* / therapeutic use
Respiratory Insufficiency* / drug therapy
Substances
Nitric Oxide
Grants and funding
K23 HL146887/HL/NHLBI NIH HHS/United States
R01 HL160982/HL/NHLBI NIH HHS/United States
R01 HL163081/HL/NHLBI NIH HHS/United States
R01 HL163852/HL/NHLBI NIH HHS/United States